Skip to main content
. 2020 Jan 25;225(2):639–667. doi: 10.1007/s00429-020-02026-5

Table 2.

Antibodies directed against other targets used in this study

Target Antibody used
GFAP Santa Cruz Biotech, Cat# sc-33673, RRID:AB_627673
Aldhl1 Abcam, Cat# ab177463, RRID: AB_2811300
Myelin basic protein Abcam, Cat# ab24567, RRID:AB_448144
Olig2 Abcam, Cat# ab109186, RRID: AB_10861310
IBA1 Abcam, Cat# ab107159, RRID:AB_10972670
Succinyl-lysine NovoPro, Cat# 106768, RRID:AB_2732922
VDAC1 Abcam, Cat# ab154856, RRID:AB_2687466
SUCLG1 Abcam, Cat# ab97867, RRID:AB_10678848
SUCLG2 Atlas Antibodies, Cat# HPA046705, RRID:AB_2679762
SUCLA2 Proteintech Group, Cat# 12627-1-AP, RRID:AB_2271200
β-actin Abcam, Cat# ab6276, RRID:AB_2223210